Abiraterone
The serum concentration of Ranitidine can be increased when it is combined with Abiraterone.
Acetohexamide
The serum concentration of Acetohexamide can be increased when it is combined with Ranitidine.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Ranitidine.
Advertisement
Amiodarone
The metabolism of Ranitidine can be decreased when combined with Amiodarone.
Amphetamine
Amphetamine may decrease the sedative activities of Ranitidine.
Apalutamide
The serum concentration of Ranitidine can be decreased when it is combined with Apalutamide.
Advertisement
Armodafinil
The metabolism of Ranitidine can be decreased when combined with Armodafinil.
Artemether
The metabolism of Ranitidine can be decreased when combined with Artemether.
Asunaprevir
The serum concentration of Asunaprevir can be increased when it is combined with Ranitidine.
Advertisement
Atazanavir
The serum concentration of Atazanavir can be decreased when it is combined with Ranitidine.
Atomoxetine
The metabolism of Ranitidine can be decreased when combined with Atomoxetine.
Atorvastatin
The risk or severity of adverse effects can be increased when Ranitidine is combined with Atorvastatin.
Azithromycin
The metabolism of Ranitidine can be decreased when combined with Azithromycin.
Benzphetamine
Benzphetamine may decrease the sedative activities of Ranitidine.
Benzylpenicilloyl polylysine
Ranitidine may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent.
BETAHISTINE
The therapeutic efficacy of Betahistine can be decreased when used in combination with Ranitidine.
Betaxolol
The metabolism of Ranitidine can be decreased when combined with Betaxolol.
Bortezomib
The metabolism of Ranitidine can be decreased when combined with Bortezomib.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Ranitidine.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Ranitidine.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Ranitidine.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Ranitidine.
Bupropion
The metabolism of Ranitidine can be decreased when combined with Bupropion.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Ranitidine.
Caffeine
The metabolism of Ranitidine can be decreased when combined with Caffeine.
Carbamazepine
The metabolism of Ranitidine can be increased when combined with Carbamazepine.
Cefditoren
The serum concentration of Cefditoren can be decreased when it is combined with Ranitidine.
Cefpodoxime
Ranitidine can cause a decrease in the absorption of Cefpodoxime resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cefuroxime
Ranitidine can cause a decrease in the absorption of Cefuroxime resulting in a reduced serum concentration and potentially a decrease in efficacy.
Celecoxib
The metabolism of Ranitidine can be decreased when combined with Celecoxib.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Ranitidine.
Chloramphenicol
The metabolism of Ranitidine can be decreased when combined with Chloramphenicol.
Chloroquine
The metabolism of Ranitidine can be decreased when combined with Chloroquine.
Chlorpromazine
The metabolism of Ranitidine can be decreased when combined with Chlorpromazine.
Chlorpropamide
The serum concentration of Chlorpropamide can be increased when it is combined with Ranitidine.
Cholecalciferol
The metabolism of Ranitidine can be decreased when combined with Cholecalciferol.
Cimetidine
The metabolism of Ranitidine can be decreased when combined with Cimetidine.
Cinacalcet
The metabolism of Ranitidine can be decreased when combined with Cinacalcet.
Citalopram
The metabolism of Ranitidine can be decreased when combined with Citalopram.
Clemastine
The metabolism of Ranitidine can be decreased when combined with Clemastine.
Clobazam
The metabolism of Ranitidine can be decreased when combined with Clobazam.
Clomipramine
The metabolism of Ranitidine can be decreased when combined with Clomipramine.
Clotrimazole
The metabolism of Ranitidine can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Ranitidine can be decreased when combined with Clozapine.
Cobicistat
The serum concentration of Ranitidine can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Ranitidine can be decreased when combined with Cocaine.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Ranitidine.
Curcumin
The metabolism of Ranitidine can be decreased when combined with Curcumin.
Cyproterone Acetate
The serum concentration of Ranitidine can be decreased when it is combined with Cyproterone acetate.
Cysteamine
The therapeutic efficacy of Cysteamine can be decreased when used in combination with Ranitidine.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Ranitidine.
Dabrafenib
The serum concentration of Ranitidine can be decreased when it is combined with Dabrafenib.
Darifenacin
The metabolism of Ranitidine can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Ranitidine can be increased when it is combined with Darunavir.
Dasatinib
Ranitidine can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dasatinib Anhydrous
Ranitidine can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deferasirox
The serum concentration of Ranitidine can be increased when it is combined with Deferasirox.
Delavirdine
Ranitidine can cause a decrease in the absorption of Delavirdine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Desipramine
The metabolism of Ranitidine can be decreased when combined with Desipramine.
Dexmethylphenidate
Ranitidine can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Dextroamphetamine
Dextroamphetamine may decrease the sedative activities of Ranitidine.
Diethylpropion
Diethylpropion may decrease the sedative activities of Ranitidine.
Dihydroergocornine
The risk or severity of adverse effects can be increased when Dihydroergocornine is combined with Ranitidine.
Dihydroergocristine
The risk or severity of adverse effects can be increased when Dihydroergocristine is combined with Ranitidine.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ranitidine.
Diphenhydramine
The metabolism of Ranitidine can be decreased when combined with Diphenhydramine.
Dothiepin
The metabolism of Ranitidine can be decreased when combined with Dosulepin.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Ranitidine.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Ranitidine.
Dronedarone
The metabolism of Ranitidine can be decreased when combined with Dronedarone.
Duloxetine
The metabolism of Ranitidine can be decreased when combined with Duloxetine.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Ranitidine.
Efavirenz
The metabolism of Ranitidine can be decreased when combined with Efavirenz.
Eliglustat
The metabolism of Ranitidine can be decreased when combined with Eliglustat.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Ranitidine.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Ranitidine.
Erlotinib
The serum concentration of Erlotinib can be decreased when it is combined with Ranitidine.
Eslicarbazepine Acetate
The metabolism of Ranitidine can be decreased when combined with Eslicarbazepine acetate.
Esomeprazole
The metabolism of Ranitidine can be decreased when combined with Esomeprazole.
Etravirine
The metabolism of Ranitidine can be decreased when combined with Etravirine.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Ranitidine.
Ferric Carboxymaltose
Ranitidine can cause a decrease in the absorption of Ferric Carboxymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric Pyrophosphate
Ranitidine can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Ranitidine.
Fluconazole
The metabolism of Ranitidine can be decreased when combined with Fluconazole.
Fluoxetine
The metabolism of Ranitidine can be decreased when combined with Fluoxetine.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Ranitidine.
Fluvoxamine
The metabolism of Ranitidine can be decreased when combined with Fluvoxamine.
Fosamprenavir
The serum concentration of Fosamprenavir can be decreased when it is combined with Ranitidine.
Fosphenytoin
The metabolism of Ranitidine can be increased when combined with Fosphenytoin.
Gefitinib
The serum concentration of Gefitinib can be decreased when it is combined with Ranitidine.
Gemfibrozil
The metabolism of Ranitidine can be decreased when combined with Gemfibrozil.
Glibornuride
The serum concentration of Glibornuride can be increased when it is combined with Ranitidine.
Gliclazide
The serum concentration of Gliclazide can be increased when it is combined with Ranitidine.
Glimepiride
The serum concentration of Glimepiride can be increased when it is combined with Ranitidine.
Glipizide
The serum concentration of Glipizide can be increased when it is combined with Ranitidine.
Gliquidone
The serum concentration of Gliquidone can be increased when it is combined with Ranitidine.
Glyburide
The serum concentration of Glyburide can be increased when it is combined with Ranitidine.
Haloperidol
The metabolism of Ranitidine can be decreased when combined with Haloperidol.
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Ranitidine.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Ranitidine.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Ranitidine.
Imipramine
The metabolism of Ranitidine can be decreased when combined with Imipramine.
Indinavir
The serum concentration of Indinavir can be decreased when it is combined with Ranitidine.
INDINAVIR ANHYDROUS
The serum concentration of Indinavir can be decreased when it is combined with Ranitidine.
Iron
Ranitidine can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Carbonyl
Ranitidine can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Sucrose
Ranitidine can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron-Dextran Complex
Ranitidine can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Isavuconazole
The serum concentration of Ranitidine can be increased when it is combined with Isavuconazole.
Isoniazid
The metabolism of Ranitidine can be decreased when combined with Isoniazid.
Itraconazole
The serum concentration of Itraconazole can be decreased when it is combined with Ranitidine.
Ketoconazole
The serum concentration of Ketoconazole can be decreased when it is combined with Ranitidine.
Ledipasvir
The serum concentration of Ledipasvir can be decreased when it is combined with Ranitidine.
Lidocaine
The metabolism of Ranitidine can be decreased when combined with Lidocaine.
Lisdexamfetamine
Lisdexamfetamine may decrease the sedative activities of Ranitidine.
Lisdexamfetamine Dimesylate
Lisdexamfetamine may decrease the sedative activities of Ranitidine.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Ranitidine.
Lopinavir
The metabolism of Ranitidine can be decreased when combined with Lopinavir.
Lorcaserin
The metabolism of Ranitidine can be decreased when combined with Lorcaserin.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Ranitidine.
Luliconazole
The serum concentration of Ranitidine can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Ranitidine can be decreased when it is combined with Lumacaftor.
Lumefantrine
The metabolism of Ranitidine can be decreased when combined with Lumefantrine.
Manidipine
The metabolism of Ranitidine can be decreased when combined with Manidipine.
Mephentermine
Mephentermine may decrease the sedative activities of Ranitidine.
Mesalamine
The therapeutic efficacy of Mesalazine can be decreased when used in combination with Ranitidine.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Ranitidine.
Methadone
The metabolism of Ranitidine can be decreased when combined with Methadone.
Methamphetamine
Methamphetamine may decrease the sedative activities of Ranitidine.
Methotrimeprazine
The metabolism of Ranitidine can be decreased when combined with Methotrimeprazine.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Ranitidine.
Methylphenidate
Ranitidine can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Ranitidine.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Ranitidine.
Mexiletine
The metabolism of Ranitidine can be decreased when combined with Mexiletine.
Midostaurin
The metabolism of Ranitidine can be decreased when combined with Midostaurin.
Mirabegron
The metabolism of Ranitidine can be decreased when combined with Mirabegron.
Moclobemide
The metabolism of Ranitidine can be decreased when combined with Moclobemide.
Modafinil
The metabolism of Ranitidine can be decreased when combined with Modafinil.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Ranitidine.
Nelfinavir
The serum concentration of Nelfinavir can be decreased when it is combined with Ranitidine.
Nevirapine
The metabolism of Ranitidine can be decreased when combined with Nevirapine.
Nicardipine
The metabolism of Ranitidine can be decreased when combined with Nicardipine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Ranitidine.
Nilotinib
The serum concentration of Nilotinib can be decreased when it is combined with Ranitidine.
Nintedanib
The serum concentration of Nintedanib can be increased when it is combined with Ranitidine.
Omeprazole
The metabolism of Ranitidine can be decreased when combined with Omeprazole.
Osimertinib
The serum concentration of Ranitidine can be decreased when it is combined with Osimertinib.
p-Hydroxyamphetamine
Hydroxyamphetamine may decrease the sedative activities of Ranitidine.
Panobinostat
The serum concentration of Ranitidine can be increased when it is combined with Panobinostat.
Pantoprazole
The metabolism of Ranitidine can be decreased when combined with Pantoprazole.
Paroxetine
The metabolism of Ranitidine can be decreased when combined with Paroxetine.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Ranitidine.
Peginterferon Alfa-2b
The serum concentration of Ranitidine can be decreased when it is combined with Peginterferon alfa-2b.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Ranitidine.
Phentermine
Phentermine may decrease the sedative activities of Ranitidine.
PHENTERMINE RESIN
Phentermine may decrease the sedative activities of Ranitidine.
Phenytoin
The metabolism of Ranitidine can be increased when combined with Phenytoin.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Ranitidine.
Posaconazole
The serum concentration of Posaconazole can be decreased when it is combined with Ranitidine.
Prasugrel
The serum concentration of the active metabolites of Prasugrel can be reduced when Prasugrel is used in combination with Ranitidine resulting in a loss in efficacy.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Ranitidine.
Procainamide
The serum concentration of Procainamide can be increased when it is combined with Ranitidine.
Promazine
The metabolism of Ranitidine can be decreased when combined with Promazine.
Pseudoephedrine
Pseudoephedrine may decrease the sedative activities of Ranitidine.
Quinidine
The metabolism of Ranitidine can be decreased when combined with Quinidine.
Quinine
The metabolism of Ranitidine can be decreased when combined with Quinine.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Ranitidine.
Rifampin
The metabolism of Ranitidine can be increased when combined with Rifampicin.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Ranitidine.
Rilpivirine
The serum concentration of Rilpivirine can be decreased when it is combined with Ranitidine.
Risedronate
Ranitidine can cause an increase in the absorption of Risedronate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Risedronic Acid
Ranitidine can cause an increase in the absorption of Risedronate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Ritonavir
The metabolism of Ranitidine can be decreased when combined with Ritonavir.
Rolapitant
The metabolism of Ranitidine can be decreased when combined with Rolapitant.
Ropinirole
The metabolism of Ranitidine can be decreased when combined with Ropinirole.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Ranitidine.
Rucaparib
The metabolism of Ranitidine can be decreased when combined with Rucaparib.
Saquinavir
The serum concentration of Saquinavir can be increased when it is combined with Ranitidine.
Saquinavir Mesylate
The serum concentration of Saquinavir can be increased when it is combined with Ranitidine.
Sertraline
The metabolism of Ranitidine can be decreased when combined with Sertraline.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Ranitidine.
Simeprevir
The metabolism of Ranitidine can be decreased when combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Ranitidine.
Sucroferric Oxyhydroxide
Ranitidine can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tenofovir Disoproxil
The metabolism of Ranitidine can be decreased when combined with Tenofovir disoproxil.
Terbinafine
The metabolism of Ranitidine can be decreased when combined with Terbinafine.
Teriflunomide
The serum concentration of Ranitidine can be decreased when it is combined with Teriflunomide.
Theophylline
The metabolism of Ranitidine can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Ranitidine can be decreased when combined with Theophylline.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Ranitidine.
Ticlopidine
The metabolism of Ranitidine can be decreased when combined with Ticlopidine.
Tipranavir
The metabolism of Ranitidine can be decreased when combined with Tipranavir.
Tizanidine
The serum concentration of Tizanidine can be increased when it is combined with Ranitidine.
Tolazamide
The serum concentration of Tolazamide can be increased when it is combined with Ranitidine.
Tolbutamide
The serum concentration of Tolbutamide can be increased when it is combined with Ranitidine.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Ranitidine.
Topiramate
The metabolism of Ranitidine can be decreased when combined with Topiramate.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Ranitidine.
Tranylcypromine
The metabolism of Ranitidine can be decreased when combined with Tranylcypromine.
Varenicline
The serum concentration of Varenicline can be increased when it is combined with Ranitidine.
Vemurafenib
The serum concentration of Ranitidine can be increased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Ranitidine can be decreased when combined with Venlafaxine.
Vincristine
The excretion of Vincristine can be decreased when combined with Ranitidine.
Voriconazole
The metabolism of Ranitidine can be decreased when combined with Voriconazole.
Warfarin
The serum concentration of Warfarin can be increased when it is combined with Ranitidine.
Ziprasidone
The metabolism of Ranitidine can be decreased when combined with Ziprasidone.
